BioMarin Pharmaceutical Inc. buy Bank of America Co.
Start price
17.09.24
/
50%
€62.80
Target price
17.09.25
€103.34
Performance (%)
-26.54%
End price
18.09.25
€46.13
Summary
This prediction ended on 18.09.25 with a price of €46.13. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.54%. Bank_of_America_Co_ has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 0.579% | 0.579% | 3.496% |
| iShares Core DAX® | -1,11 % | 0,20 % | 1,21 % |
| iShares Nasdaq 100 | -4,35 % | -3,25 % | 25,87 % |
| iShares Nikkei 225® | -6,79 % | -7,72 % | 50,97 % |
| iShares S&P 500 | -1,79 % | 0,99 % | 21,07 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Bank of America Co. from $130.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.12
11.03.26
11.03.26
€73.15
11.03.27
11.03.27
-0.04%
17.07.26
17.07.26
Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€42.92
19.05.26
19.05.26
€68.72
19.05.27
19.05.27
21.39%
17.07.26
17.07.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€98.56
20.02.26
20.02.26
-21.69%
21.02.26
21.02.26